Menu Back toArtificial-Intelligence-A-Disruptive-Journey-for-Pharmacovigilance

DIA 2018 Global Annual Meeting

Artificial Intelligence: A Disruptive Journey for Pharmacovigilance

    Session Chair(s)
      Annette S. Williams, MBA, RPh

      Annette S. Williams, MBA, RPh

      • Vice President, Lifecycle Safety
      • IQVIA, United States
    to be determined
    Learning Objective : Understand the in depth process for training cognitive systems through a practical example like MedDRA coding, including data type, volume and quality and challenges to prepare for Outline Subject Matter Expertise requirements needed to train a cognitive system along with the iterative training process Relay the ongoing training that may be required, expected results, reasons, and process
      Elenee  Argentinis, JD

      Training Artificial Intelligent System for Pharmacovigilance: Practical Considerations and Guidance

      Elenee Argentinis, JD

      • Offering Management Leader
      • IBM Watson Health, United States
      Glenn  Carroll, MBA

      The Future of Pharmacovigilance After Full Industry Disruption from Cognitive Automation

      Glenn Carroll, MBA

      • Principal, Strategy and Operations, Life Sciences
      • Deloitte Consulting, United States
      Caroline  Rosewell, MBA

      Our Journey Toward Touchless Case Management

      Caroline Rosewell, MBA

      • Senior Director, Global Patient Safety, Clinical Case Management
      • Eli Lilly and Company, United States